OKT4/OKT8 ratio and serum beta 2-microglobulin in mycosis fungoides and chronic benign dermatitis. 1986

F M Larussa, and L M Larocca, and L Rusciani, and L Pagano, and G Leone, and A Venier, and F Serri

Pre-treatment Serum Beta 2-microglobulin (S B2-m) and OKT4/OKT8 Ratio (T4/T8 R) were studied in 15 patients with Mycosis Fungoides (MF) and in 10 subjects with Chronic Superficial Benign Dermatitis (CSBD) in order to verify whether these parameters may lend support to an earlier differential diagnosis. S B2-m levels and T4/T8 R showed no significant difference in CSBD as compared to normal controls. MF patients displayed elevated S B2-m and T4/T8 R values in comparison to healthy controls and subjects suffering from CSBD (P less than 0.001). After photochemotherapy (PUVA), markedly decreased S B2-m and T4/T8 R values were observed in all patients but two who proved to be unresponsive to PUVA treatment. On the basis of reported data, S B2-m and T4/T8 R can be regarded as an additional tool to discriminate CSBD and MF when clinical and histological features are not significantly diagnostic. Finally, these parameters seem to provide reliable information in monitoring response to treatment.

UI MeSH Term Description Entries
D007958 Leukocyte Count The number of WHITE BLOOD CELLS per unit volume in venous BLOOD. A differential leukocyte count measures the relative numbers of the different types of white cells. Blood Cell Count, White,Differential Leukocyte Count,Leukocyte Count, Differential,Leukocyte Number,White Blood Cell Count,Count, Differential Leukocyte,Count, Leukocyte,Counts, Differential Leukocyte,Counts, Leukocyte,Differential Leukocyte Counts,Leukocyte Counts,Leukocyte Counts, Differential,Leukocyte Numbers,Number, Leukocyte,Numbers, Leukocyte
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009182 Mycosis Fungoides A chronic, malignant T-cell lymphoma of the skin. In the late stages, the LYMPH NODES and viscera are affected.
D011701 PUVA Therapy Photochemotherapy using PSORALENS as the photosensitizing agent and ultraviolet light type A (UVA). Psoralen Ultraviolet A Therapy,Therapy, PUVA,PUVA Therapies,Therapies, PUVA
D003872 Dermatitis Any inflammation of the skin. Dermatitides
D003937 Diagnosis, Differential Determination of which one of two or more diseases or conditions a patient is suffering from by systematically comparing and contrasting results of diagnostic measures. Diagnoses, Differential,Differential Diagnoses,Differential Diagnosis
D005260 Female Females
D006377 T-Lymphocytes, Helper-Inducer Subpopulation of CD4+ lymphocytes that cooperate with other lymphocytes (either T or B) to initiate a variety of immune functions. For example, helper-inducer T-cells cooperate with B-cells to produce antibodies to thymus-dependent antigens and with other subpopulations of T-cells to initiate a variety of cell-mediated immune functions. Helper Cell,Helper Cells,Helper T Cell,Helper-Inducer T-Lymphocytes,Inducer Cell,Inducer Cells,T-Cells, Helper-Inducer,T-Lymphocytes, Helper,T-Lymphocytes, Inducer,Helper T-Cells,Cell, Helper T,Cells, Helper T,Helper Inducer T Lymphocytes,Helper T Cells,Helper T-Cell,Helper T-Lymphocyte,Helper T-Lymphocytes,Helper-Inducer T-Cell,Helper-Inducer T-Cells,Helper-Inducer T-Lymphocyte,Inducer T-Lymphocyte,Inducer T-Lymphocytes,T Cell, Helper,T Cells, Helper,T Cells, Helper Inducer,T Lymphocytes, Helper,T Lymphocytes, Helper Inducer,T Lymphocytes, Inducer,T-Cell, Helper,T-Cell, Helper-Inducer,T-Cells, Helper,T-Lymphocyte, Helper,T-Lymphocyte, Helper-Inducer,T-Lymphocyte, Inducer
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

F M Larussa, and L M Larocca, and L Rusciani, and L Pagano, and G Leone, and A Venier, and F Serri
December 1988, Minerva medica,
F M Larussa, and L M Larocca, and L Rusciani, and L Pagano, and G Leone, and A Venier, and F Serri
January 1986, Archives of dermatology,
F M Larussa, and L M Larocca, and L Rusciani, and L Pagano, and G Leone, and A Venier, and F Serri
July 1989, British journal of addiction,
F M Larussa, and L M Larocca, and L Rusciani, and L Pagano, and G Leone, and A Venier, and F Serri
January 1985, Bollettino dell'Istituto sieroterapico milanese,
F M Larussa, and L M Larocca, and L Rusciani, and L Pagano, and G Leone, and A Venier, and F Serri
April 1986, Immunological investigations,
F M Larussa, and L M Larocca, and L Rusciani, and L Pagano, and G Leone, and A Venier, and F Serri
January 2021, Indian dermatology online journal,
F M Larussa, and L M Larocca, and L Rusciani, and L Pagano, and G Leone, and A Venier, and F Serri
May 2021, The journal of allergy and clinical immunology. In practice,
F M Larussa, and L M Larocca, and L Rusciani, and L Pagano, and G Leone, and A Venier, and F Serri
June 1981, The Tohoku journal of experimental medicine,
F M Larussa, and L M Larocca, and L Rusciani, and L Pagano, and G Leone, and A Venier, and F Serri
January 1982, Clinical and laboratory haematology,
F M Larussa, and L M Larocca, and L Rusciani, and L Pagano, and G Leone, and A Venier, and F Serri
July 1985, Orvosi hetilap,
Copied contents to your clipboard!